161
Views
4
CrossRef citations to date
0
Altmetric
Review

New therapies and management strategies in the treatment of asthma: patient-focused developments

&
Pages 1-12 | Published online: 30 Dec 2010

References

  • McFaddenERJrA century of asthmaAm J Respir Crit Care Med2004170321522115280175
  • WardlawAJBrightlingCGreenRWoltmannGPavordIEosinophils in asthma and other allergic diseasesBr Med Bull2000564985100311359633
  • DjukanovicRHomeyardSGratziouCThe effect of treatment with oral corticosteroids on asthma symptoms and airway inflammationAm J Respir Crit Care Med199715538268329117012
  • ten BrinkeAZwindermanAHSterkPJRabeKFBelEH“Refractory” eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroidsAm J Respir Crit Care Med2004170660160515215154
  • O’ByrnePMPedersenSLammCJTanWCBusseWWSevere exacerbations and decline in lung function in asthmaAm J Respir Crit Care Med20091791192418990678
  • BousquetJBousquetPJGodardPDauresJPThe public health implications of asthmaBull World Health Organ200583754855416175830
  • Asthma UKHigh cost of asthma in West Midlands Available from: http://www.asthma.org.uk/news_media/media_releases/high_cost_of_asthm_3.html. Updated 2009 Oct 22.
  • GodardPChanezPSiraudinLNicoloyannisNDuruGCosts of asthma are correlated with severity: a 1-yr prospective studyEur Respir J2001191616711843329
  • Serra-BatllesJPlazaVMorejonEComellaABruguesJCosts of asthma according to the degree of severityEur Respir J1998126132213269877485
  • BatemanEDBousheyHABousquetJCan guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control studyAm J Respir Crit Care Med2004170883684415256389
  • RabeKFVermeirePASorianoJBMaierWCClinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) studyEur Respir J200016580280711153575
  • SIGN and the British Thoracic Society (BTS)British Guideline on the Management of AsthmaEdinburgh (UK)SIGN and the British Thoracic Society (BTS)2010 Guideline No. 101,ISBN 978 1 90581 28 52008 May, Revised 2009 Jun.
  • ReddelHKTaylorDRBatemanEDAn official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceAm J Respir Crit Care Med20091801599919535666
  • Global Initiative for Asthma (GINA), National Heart Lung and Blood Institute (NHLBI)Global Strategy for Asthma Management and PreventionBethesda (MD)Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI) Available from: http://www.ginasthma.com. Updated 2010 Jan 12.
  • HaldarPPavordIDShawDECluster analysis and clinical asthma phenotypesAm J Respir Crit Care Med2008178321822418480428
  • Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic SocietyAm J Respir Crit Care Med200016262341235111112161
  • GreenRHBrightlingCEBraddingPThe reclassification of asthma based on subphenotypesCurr Opin Allergy Clin Immunol200771435017218810
  • BraddingPGreenRHSubclinical phenotypes of asthmaCurr Opin Allergy Clin Immunol2010101545919907311
  • WenzelSEAsthma: defining of the persistent adult phenotypesLancet2006368953780481316935691
  • PavordIDWardlawAJThe A to E of airway diseaseClin Exp Allergy2010401626720205696
  • GibsonPGPowellHWilsonAJSelf-management education and regular practitioner review for adults with asthmaCochrane Database Syst Rev20033CD00111712535399
  • KendrickAHHiggsCMWhitfieldMJLaszloGAccuracy of perception of severity of asthma: patients treated in general practiceBMJ199330769014224248374455
  • TattersfieldAEPostmaDSBarnesPJExacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study GroupAm J Respir Crit Care Med1999160259459910430734
  • AbramsonMJBaileyMJCouperFJAre asthma medications and management related to deaths from asthma?Am J Respir Crit Care Med20011631121811208619
  • HoltSMasoliMBeasleyRThe use of the self-management plan system of care in adult asthmaPrim Care Respir J2004131192716701633
  • RingNMalcolmCWykeSPromoting the use of personal asthma action plans: a systematic reviewPrim Care Respir J200716527128317710351
  • HaahtelaTJarvinenMKavaTComparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthmaN Engl J Med199132563883922062329
  • PauwelsRALofdahlCGPostmaDSEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticos-teroids Establishing Therapy (FACET)N Engl J Med199733720140514119358137
  • NelsonHSWeissSTBleeckerERYanceySWDorinskyPMThe Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterolChest20061291152616424409
  • WeatherallMWijesingheMPerrinKHarwoodMBeasleyRMeta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapyThorax2010651394320029037
  • US Food and Drug Administration, FDALong-Acting Beta-Agonists (LABAs): New Safe Use RequirementsSilver Spring (MD)FDA Available from: http://www.fda.gov/Safety/MedWatch/SafetyInfor-mation/SafetyAlertsforHumanMedicalProducts/ucm201003.htm. Accessed 2010 Oct 22.
  • van NoordJASmeetsJJRaaijmakersJABommerAMMaesenFPSalmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actionEur Respir J199698168416888866595
  • JatakanonALimSBarnesPJChanges in sputum eosinophils predict loss of asthma controlAm J Respir Crit Care Med20001611647210619799
  • KornSHJerreABrattsandREffects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cellsEur Respir J20011761070107711491146
  • BaraniukJNAliMBrodyDGlucocorticoids induce beta2-adrenergic receptor function in human nasal mucosaAm J Respir Crit Care Med199715527047109032216
  • MakJCNishikawaMBarnesPJGlucocorticosteroids increase beta 2-adrenergic receptor transcription in human lungAm J Physiol19952681 Pt 1L41L467840227
  • O’ByrnePMBisgaardHGodardPPBudesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med2005171212913615502112
  • BousquetJBouletLPPetersMJBudesonide/formoterol for maintenance and relief in uncontrolled asthma vs high-dose salmeterol/fluticasoneRespir Med2007101122437244617905575
  • BatemanEDReddelHKErikssonGOverall asthma control: the relationship between current control and future riskJ Allergy Clin Immunol2010125360060820153029
  • PavordIDJefferyPKQiuYAirway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterolJ Allergy Clin Immunol200912351083108919368965
  • BosleyCMParryDTCochraneGMPatient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance?Eur Respir J1994735045098013609
  • SovaniMPWhaleCIOborneJPoor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Br J Gen Pract200858546374318186995
  • PavordIDShawDEGibsonPGTaylorDRInflammometry to assess airway diseasesLancet200837296431017101918805315
  • PavordIDPizzichiniMMPizzichiniEHargreaveFEThe use of induced sputum to investigate airway inflammationThorax19975264985019227713
  • BrightlingCEWardRGohKLWardlawAJPavordIDEosinophilic bronchitis is an important cause of chronic coughAm J Respir Crit Care Med1999160240641010430705
  • GreenRHBrightlingCEMcKennaSAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet200236093471715172112480423
  • JayaramLPizzichiniMMCookRJDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEur Respir J200627348349416507847
  • HoustonJCde NavasquezSTrounceJRA clinical and pathological study of fatal cases of status asthmaticusThorax19538320721313102418
  • BrownHMTreatment of chronic asthma with prednisolone; significance of eosinophils in the sputumLancet1958270591245124713612182
  • KankaanrantaHLindsayMAGiembyczMAZhangXMoilanenEBarnesPJDelayed eosinophil apoptosis in asthmaJ Allergy Clin Immunol20001061778310887309
  • HunterCJBrightlingCEWoltmannGWardlawAJPavordIDA comparison of the validity of different diagnostic tests in adults with asthmaChest200212141051105711948032
  • FranklinPJTaplinRStickSMA community study of exhaled nitric oxide in healthy childrenAm J Respir Crit Care Med1999159169739872820
  • KharitonovSAYatesDBarnesPJIncreased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infectionsEur Respir J1995822952977538934
  • MalmbergLPPelkonenASHaahtelaTTurpeinenMExhaled nitric oxide rather than lung function distinguishes preschool children with probable asthmaThorax200358649449912775859
  • OlinACBakeBTorenKFraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokersChest200713161852185617565022
  • SmithADCowanJOFilsellSDiagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional testsAm J Respir Crit Care Med2004169447347814644933
  • KharitonovSAYatesDRobbinsRALogan-SinclairRShinebourneEABarnesPJIncreased nitric oxide in exhaled air of asthmatic patientsLancet199434388901331357904001
  • ShawDEBerryMAThomasMThe use of exhaled nitric oxide to guide asthma management: a randomized controlled trialAm J Respir Crit Care Med2007176323123717496226
  • de JongsteJCCarraroSHopWCBaraldiEDaily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthmaAm J Respir Crit Care Med20091792939718931330
  • PetskyHLCatesCJLiAKynastonJATurnerCChangABTailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adultsCochrane Database Syst Rev20094CD00634019821360
  • GambleJStevensonMMcCleanEHeaneyLGThe prevalence of nonadherence in difficult asthmaAm J Respir Crit Care Med2009180981782219644048
  • MurphyAProeschelALinnettMEBraddingPGreenRHOral abstract sessionsAllergy201065177
  • LeungDYBloomJWUpdate on glucocorticoid action and resistanceJ Allergy Clin Immunol2003111132212532089
  • van der PalenJKleinJJvan HerwaardenCLZielhuisGASeydelERMultiple inhalers confuse asthma patientsEur Respir J19991451034103710596686
  • BouletLPPerception of the role and potential side effects of inhaled corticosteroids among asthmatic patientsChest199811335875929515829
  • BenderBMilgromHRCNonadherence in asthmatic patients: is there a solution to the problem?Ann Allergy Asthma Immunol1997793177185 quiz1851869305223
  • JansonSLMcGrathKWCovingtonJKChengSCBousheyHAIndividualized asthma self-management improves medication adherence and markers of asthma controlJ Allergy Clin Immunol2009123484084619348923
  • MashBBheekieAJonesPWInhaled vs oral steroids for adults with chronic asthmaCochrane Database Syst Rev20011CD00216011279754
  • McGivneySAOgiralaRGEffect of high-dose intramuscular triamcinolone in older adults with severe, chronic asthmaLung1994172273788114514
  • WardlawAJSilvermanMSivaRPavordIDGreenRMulti-dimensional phenotyping: towards a new taxonomy for airway diseaseClin Exp Allergy200535101254126216238783
  • SunyerJJarvisDPekkanenJGeographic variations in the effect of atopy on asthma in the European Community Respiratory Health StudyJ Allergy Clin Immunol200411451033103915536406
  • HumbertMBeasleyRAyresJBenefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEAllergy200560330931615679715
  • DjukanovicRWilsonSJKraftMEffects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthmaAm J Respir Crit Care Med2004170658359315172898
  • WalkerSMonteilMPhelanKLassersonTJWaltersEHAnti-IgE for chronic asthma in adults and childrenCochrane Database Syst Rev20062CD00355916625585
  • Genentech, IncXolair(R) (omalizumab for subcutaneous use) package insertSouth San Francisco, CA2003
  • HargadonBHaldarPShawDEligibility for treatment with omalizumab among patients attending the Glenfield Hospital Refractory Asthma ClinicThorax200661Suppl 2ii57ii133
  • AdelrothERakSHaahtelaTRecombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitisJ Allergy Clin Immunol2000106225325910932067
  • EpsteinFHChoyEHSPanayiGSCytokine pathways and joint inflammation in rheumatoid arthritisN Engl J Med200934412907916
  • OhkawaraYYamauchiKTannoYHuman lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggeringAm J Respir Cell Mol Biol1992743853921382477
  • BerryMAHargadonBShelleyMEvidence of a role of tumor necrosis factor α in refractory asthmaN Engl J Med2009354769770816481637
  • HowarthPHBabuKSArshadHSTumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthmaThorax200560121012101816166100
  • MorjariaJBChauhanAJBabuKSPolosaRDaviesDEHolgateSTThe role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trialThorax200863758459118245148
  • WenzelSEBarnesPJBleeckerERA randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaAm J Respir Crit Care Med2009179754955819136369
  • BongartzTSuttonAJSweetingMJBuchanIMattesonELMontoriVAnti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsJAMA2006295192275228516705109
  • LeckieMJten BrinkeAKhanJEffects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic responseLancet200035692482144214811191542
  • GibsonPGDolovichJDenburgJRamsdaleEHHargreaveFEChronic cough: eosinophilic bronchitis without asthmaLancet198918651134613482567371
  • HaldarPBrightlingCEHargadonBMepolizumab and exacerbations of refractory eosinophilic asthmaN Engl J Med20093601097398419264686
  • Flood-PagePSwensonCFaifermanIA study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthmaAm J Respir Crit Care Med2007176111062107117872493
  • NairPPizzichiniMMKjarsgaardMMepolizumab for prednisone-dependent asthma with sputum eosinophiliaN Engl J Med20093601098599319264687
  • Dose Ranging Efficacy and Safety with Mepolizumab in Severe Asthma (DREAM) Available from: clinicaltrials.gov/ct2/show/NCT01000506. Updated 2010 Jul 15.
  • BlackPNUdyAABrodieSMSensitivity to fungal allergens is a risk factor for life-threatening asthmaAllergy200055550150410843433
  • FairsAAgbetileJHargadonBIgE sensitisation to aspergillus fumigatus is associated with reduced lung function in asthmaAm J Respir Crit Care Med2010 201001-0087OC.
  • DenningDWO’DriscollBRHogaboamCMBowyerPNivenRMThe link between fungi and severe asthma: a summary of the evidenceEur Respir J200627361562616507864
  • WarkPAGibsonPGWilsonAJAzoles for allergic bronchopulmonary aspergillosis associated with asthmaCochrane Database Syst Rev20033CD00110812917898
  • DenningDWO’DriscollBRPowellGRandomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) studyAm J Respir Crit Care Med20091791111818948425
  • HopeWWBillaudEMLestnerJDenningDWTherapeutic drug monitoring for triazolesCurr Opin Infect Dis200821658058618978525
  • CastroMRubinASLavioletteMEffectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trialAm J Respir Crit Care Med2010181211612419815809
  • PavordIDCoxGThomsonNCSafety and efficacy of bronchial thermoplasty in symptomatic, severe asthmaAm J Respir Crit Care Med2007176121185119117901415